Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
GET THE APP
Treatment Of The Hepatitis C In Prison In France During 2011-2012: More Patients Treated In Fewer Sanitary Units; Results Of National Practice Survey | 25226
ISSN: 2161-069X
Journal of Gastrointestinal & Digestive System
Open Access
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Introduction: Treatment of hepatitis C was until 2011 dual therapy (peg-interferon and ribavirin) before two direct antiviral
agents, telaprevir and boceprevir were available. At time of dual therapy, only 14% of inmates with hepatitis C were treated.
Objectives and methods: Objective was to study in national survey, over 2011/2012, number of patients treated in MJU
(Medical Jailhouse Unit), with dual or triple therapy.
Preliminary results: Hepatitis screening was systematically proposed in 100% of MJU; 27622 serologies C were annually
realized with rate of 3.1% positivity; followed patients were 1544 in 2011 and 1321 in 2012 (4.2%); 49% of MJU had regular
hepatology consultation; to evaluate liver fibrosis 227 FIBROSCAN* and 511 FIBROTEST were realized in 2012. In 2011, 261
patients were treated (16.9%) and in 2012, 332 patients (25%). Triple therapy constituted 12% of treatment in 2011, 39% in
2012 (telaprevir 78%, boceprevir 28%); 42% of the MJU introduced no treatment in 2011 (77% any triple therapy) and 56% in
2012 (66% any triple therapy).
Conclusions: Frequent positive patients VHC in jailhouses, good screening and diagnosis and using widely not invasive
methods of fibrosis but different practices for hepatitis treatment between MJU treating a lot of patients and MJU treating
none. Compared with the study of 2005, percentage of treated patients was doubled but percentage of MJU involved decreased
to 45%.
Biography
Andr?-Jean Remy has completed his PhD at the age of 31 years from University of Montpellier, France. He is department head of Hepato/Gastroenterology and
Medical Jailhouse Unit of Perpignan Hospital. He has published 66 papers in reputed medical journals and national/international congresses, specially on viral
hepatitis in inmates and drugs users.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals